Company Flexion Therapeutics, Inc.
Equities
FLXN
US33938J1060
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Compliance Officer | - | 16-08-31 | |
Scott A. Young
IRC | Investor Relations Contact | - | 16-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,321,366 | 48,104,888 ( 95.60 %) | 0 | 95.60 % |
Company contact information
Flexion Therapeutics, Inc.
10 Mall Road Suite 301
01803, Burlington
+781 305 7777
http://www.flexiontherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
-0.49% | 103B | |
+3.31% | 96.73B | |
+1.66% | 21.31B | |
-16.16% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.87% | 13.68B | |
+6.32% | 13.44B | |
+21.46% | 10.98B |